American Board of Family Medicine

Prescription Drugs

You have access
Perceptions and Preferences for Defining Biosimilar Products in Prescription Drug Promotion
Mihaela Johnson, Jessica E. Thompson, Avery A. Tilley, Amie C. O’Donoghue and Kathryn J. Aikin

The Journal of the American Board of Family Medicine January 2025, 38 (1) 94-106; DOI: https://doi.org/10.3122/jabfm.2024.240151R1
You have access
Pharmacy Benefit Managers in the Eye of the Storm: Growing Multipartite Scrutiny
Eli Y. Adashi, Daniel P. O’Mahony and David S. Guzick

The Journal of the American Board of Family Medicine November 2023, 36 (6) 1065-1067; DOI: https://doi.org/10.3122/jabfm.2023.230102R1
You have access
Direct-to-Consumer Prescription Drug Advertising and Patient-Provider Interactions
Helen W. Sullivan, Kathryn J. Aikin, Jennifer Berktold, Karen L. Stein and Victoria J. Hoverman

The Journal of the American Board of Family Medicine March 2020, 33 (2) 279-283; DOI: https://doi.org/10.3122/jabfm.2020.02.190278
You have access
Using Drug Prescribing Patterns to Identify Stewards of Cost-Conscious Care
Nicole Michele Gastala, Peter Wingrove, Winston Liaw, Stephen Petterson and Andrew Bazemore

The Journal of the American Board of Family Medicine November 2017, 30 (6) 824-827; DOI: https://doi.org/10.3122/jabfm.2017.06.170019
You have access
Primary Care Physicians' Use of FDA-Approved Prescription Drug Labels
Helen W. Sullivan, Amie C. O'Donoghue and Kathryn J. Aikin

The Journal of the American Board of Family Medicine September 2014, 27 (5) 694-698; DOI: https://doi.org/10.3122/jabfm.2014.05.140039

Main menu

User menu

Search

American Board of Family Medicine

Prescription Drugs

Navigate

Authors & Reviewers

Other Services

Other Resources